Regulatory Services in USA | DDReg Pharma

Our Regulatory Services in USA include services for New Drug Applications (NDA) as per section 5.5(b)(2) and Abbreviated New Drug Applications (ANDA) as per section 505(j). All modules of the dossiers and necessary documents are reviewed per the US FDA parameters. For more information, contact at +1 (302) 391-6010 & visit online https://bit.ly/3DPTrua